Valentina Damato

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Journal: Neurology
Published: May 26, 2026

Correction to: Italian recommendations for the diagnosis and treatment of myasthenia gravis.

Correction to: Italian recommendations for the diagnosis and treatment of myasthenia gravis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: May 08, 2026

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Journal: Research square
Published: March 27, 2026

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Journal: Research square
Published: March 27, 2026

Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.

Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.

Journal: Nature communications
Published: March 11, 2026

Validation of the MOG-AR Score: A Retrospective Multicenter Study.

Validation of the MOG-AR Score: A Retrospective Multicenter Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 28, 2026

Italian recommendations for the diagnosis and treatment of myasthenia gravis.

Italian recommendations for the diagnosis and treatment of myasthenia gravis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: December 26, 2025

Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.

Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.

Journal: Breast cancer research : BCR
Published: December 22, 2025

Half a century of change: demographic trends and their clinical impact in acetylcholine receptor antibody-positive myasthenia gravis.

Half a century of change: demographic trends and their clinical impact in acetylcholine receptor antibody-positive myasthenia gravis.

Journal: Journal of neurology
Published: December 01, 2025

Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.

Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 21, 2025

Typical and atypical clinical presentations.

Typical and atypical clinical presentations.

Journal: International review of neurobiology
Published: October 16, 2025

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences
Published: October 06, 2025
Showing 1-12 of 97

Last Updated: 09/26/2026